The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 26, 2019

Filed:

Oct. 04, 2016
Applicants:

California State University, Fresno, Fresno, CA (US);

Mayo Foundation for Medical Education and Research, Rochester, MN (US);

Inventors:

Santanu Maitra, Clovis, CA (US);

Jungsu Kim, Ponte Vedra, FL (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 295/26 (2006.01); C07C 233/65 (2006.01); C07D 295/195 (2006.01); C07C 311/16 (2006.01); C07D 295/03 (2006.01); C07C 211/30 (2006.01); A61K 31/166 (2006.01); A61K 31/5375 (2006.01); A61K 31/40 (2006.01); A61K 31/4453 (2006.01); A61K 31/18 (2006.01); A61K 31/137 (2006.01); A61K 31/167 (2006.01); C07C 233/75 (2006.01); C07C 233/64 (2006.01); C07C 311/21 (2006.01); C07C 311/20 (2006.01);
U.S. Cl.
CPC ...
C07D 295/26 (2013.01); A61K 31/137 (2013.01); A61K 31/166 (2013.01); A61K 31/167 (2013.01); A61K 31/18 (2013.01); A61K 31/40 (2013.01); A61K 31/4453 (2013.01); A61K 31/5375 (2013.01); C07C 211/30 (2013.01); C07C 233/64 (2013.01); C07C 233/65 (2013.01); C07C 233/75 (2013.01); C07C 311/16 (2013.01); C07C 311/20 (2013.01); C07C 311/21 (2013.01); C07D 295/03 (2013.01); C07D 295/195 (2013.01); C07C 2101/14 (2013.01);
Abstract

This invention offers an effective method of decreasing expression of apolipoprotein E and increasing expression of at least one of either LDL-receptor protein or AbcA1 protein including selecting mammalian cells expressing apoE and at least one of either LDL-receptor protein or AbcA1 protein, contacting the mammalian cell with an effective amount of a compound having general formula (I) or general formula (II) in an amount sufficient to decrease expression of the apoE and increase expression of at least one of the LDL-receptor protein or the AbcA1 protein in the mammalian cell.


Find Patent Forward Citations

Loading…